Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Max Healthcare InstituteNSE:MAXHEALTH -0.18%94 Days Payable is 178.34 as of Mar. 2026, which is 6% below its 10-year median of 190.49. GuruFocus rates NSE:MAXHEALTH with a GF Score™ of 94/100 and a GF Value™ of ₹1,434.47 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 606 Healthcare Providers & Services companies, Max Healthcare Institute ranks better than 82.18% on this metric.
The historical rank and industry rank for Max Healthcare Institute's Days Payable or its related term are showing as below:
NSE:MAXHEALTH'
s Days Payable Range Over the Past 10 Years
Min: 169.19 Med: 190.49 Max: 395.74
Current: 171.49
During the past 12 years, Max Healthcare Institute's highest Days Payable was 395.74. The lowest was 169.19. And the median was 190.49.
NSE:MAXHEALTH's Days Payable is ranked better than 82.18% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 57.105
vs NSE:MAXHEALTH: 171.49
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MAXHEALTH vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Max Healthcare Institute's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Max Healthcare Institute Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Max Healthcare Institute's Days Payable distribution charts can be found below:
* The bar in red indicates where Max Healthcare Institute's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Max Healthcare Institute's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Max Healthcare Institute (NSE:MAXHEALTH) has a Days Payable of 178.34 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Max Healthcare Institute and its competitors. This is near median its historical median of 190.49. Over the past decade, Max Healthcare Institute's Days Payable has ranged from 169.19 to 395.74. According to the industry distribution chart, Max Healthcare Institute ranks #108 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 17.8%.
Is Max Healthcare Institute's Days Payable too high?
Max Healthcare Institute's current Days Payable of 178.34 is near median its 10-year median of 190.49. Over the past 10 years, this metric has ranged from a low of 169.19 to a high of 395.74. The Healthcare Providers & Services industry median Days Payable is 57.11. Max Healthcare Institute's value of 178.34 is 212.3% above this industry median. Based on the distribution chart, Max Healthcare Institute ranks #108 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Max Healthcare Institute has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max Healthcare Institute's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Max Healthcare Institute ranks #108 out of 606 companies for Days Payable. This places Max Healthcare Institute in the top 18% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.11. Max Healthcare Institute's value of 178.34 is 212.3% above this benchmark. Historically, Max Healthcare Institute's own Days Payable has ranged from 169.19 to 395.74 over the past decade. While the company's 10-year median is 190.49 vs. the industry median of 57.11, Max Healthcare Institute has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.11, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Max Healthcare Institute's current Days Payable of 178.34 is 212.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Max Healthcare Institute and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Max Healthcare Institute's current Days Payable is 178.34, which is near median its own 10-year median of 190.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max Healthcare Institute stock overvalued right now?
Based on GuruFocus' analysis, Max Healthcare Institute (NSE:MAXHEALTH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,434.47, compared to a current price of ₹1,100.40 — trading 23.3% below its estimated fair value. The current Days Payable is 178.34, which is near median its 10-year median of 190.49 and 212.3% above the Healthcare Providers & Services industry median of 57.11. Max Healthcare Institute's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Max Healthcare Institute (NSE:MAXHEALTH), the current Days Payable is 178.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Max Healthcare Institute (NSE:MAXHEALTH) Overvalued in 2026?
Based on GuruFocus' analysis, Max Healthcare Institute stock appears to be undervalued.
The current stock price of ₹1,100.40 is trading 23.3% below its estimated GF Value™ of ₹1,434.47.
GuruFocus considers Max Healthcare Institute to be Modestly Undervalued.
Key valuation signals for NSE:MAXHEALTH:
Days Payable: 178.34 (near median its 10-year median of 190.49)
GF Value™: ₹1,434.47 vs. price of ₹1,100.40 (23.3% below fair value)
Industry Position: 212.3% above the Healthcare Providers & Services median (#108 of 606)
No single metric tells the full story. See the NSE:MAXHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
94GF Score
Get the complete analysis for NSE:MAXHEALTH
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAXHEALTH has been successfully added to your 
